Literature DB >> 839231

Liposome toxicity in the mouse central nervous system.

D H Adams, G Joyce, V J Richardson, B E Ryman, H M Wiśniewski.   

Abstract

This study has shown that while some liposomes are highly toxic to the central nervous system, others, of different composition, are tolerated well in the dosage used (0.02-0.05 ml = 4-12 mg of lipid/inoculum). Those composed of lecithin-cholesterol-dicetyl phosphate or lecithin-cholesterol-stearylamine produced generalised epileptic seizures and some deaths due to respiratory failure immediately after injection,and a subsequent widespread tissue necrosis. However liposomes composed of lecithin-cholesterol-phosphatidic acid, or dipalmitoyl lecithin only, produced minimal morphological changes and by the sixth day post-injection the pathology was limited to the mechanical trauma caused by the injection. It is concluded that liposomes of appropriate composition may be sufficiently benign to use as carriers of therapeutic agents into the CNS.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 839231     DOI: 10.1016/0022-510x(77)90104-6

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  17 in total

1.  Intraneoplastic application of metrizamide-containing liposomes: kinetic studies with computed tomography.

Authors:  B Wowra; K Cremer; H Stricker; W J Zeller
Journal:  J Neurooncol       Date:  1992-09       Impact factor: 4.130

2.  Therapy of leishmaniasis: superior efficacies of liposome-encapsulated drugs.

Authors:  C R Alving; E A Steck; W L Chapman; V B Waits; L D Hendricks; G M Swartz; W L Hanson
Journal:  Proc Natl Acad Sci U S A       Date:  1978-06       Impact factor: 11.205

3.  Application of radioimmunoassay to monitor treatment of human cerebral gliomas with bleomycin entrapped within liposomes.

Authors:  G B Firth; M Firth; R O McKeran; J Rees; P Walter; D Uttley; V Marks
Journal:  J Clin Pathol       Date:  1988-01       Impact factor: 3.411

4.  Effects of phospholipid chain length, concentration, charge, and vesicle size on pulmonary insulin absorption.

Authors:  Y Li; A K Mitra
Journal:  Pharm Res       Date:  1996-01       Impact factor: 4.200

Review 5.  Targeting neuroinflammation by intranasal delivery of nanoparticles in neurological diseases: a comprehensive review.

Authors:  Fatemeh Moradi; Nasrin Dashti
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2022-01-04       Impact factor: 3.000

6.  Liposomal enhancement of the immunogenicity of adenovirus type 5 hexon and fiber vaccines.

Authors:  W J Kramp; H R Six; S Drake; J A Kasel
Journal:  Infect Immun       Date:  1979-08       Impact factor: 3.441

7.  Toxicity and neuronal transport of stable liposomes and phospholipid in the nervous system.

Authors:  D S Deshmukh; K Kristensson; H M Wisniewski; H Brockerhoff
Journal:  Neurochem Res       Date:  1981-02       Impact factor: 3.996

8.  A potential application for the intracerebral injection of drugs entrapped within liposomes in the treatment of human cerebral gliomas.

Authors:  R O McKeran; G Firth; S Oliver; D Uttley; S O'Laoire
Journal:  J Neurol Neurosurg Psychiatry       Date:  1985-12       Impact factor: 10.154

9.  Control of in vitro cytotoxicity of positively charged liposomes.

Authors:  E A Panzner; V K Jansons
Journal:  J Cancer Res Clin Oncol       Date:  1979-09       Impact factor: 4.553

10.  Studies on the intracerebral injection of bleomycin free and entrapped within liposomes in the rat.

Authors:  G Firth; A S Oliver; R O McKeran
Journal:  J Neurol Neurosurg Psychiatry       Date:  1984-06       Impact factor: 10.154

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.